nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—ESR1—osteoporosis	0.314	1	CbGaD
Naloxone—ESR1—Estropipate—osteoporosis	0.0903	0.178	CbGbCtD
Naloxone—ESR1—Raloxifene—osteoporosis	0.0602	0.119	CbGbCtD
Naloxone—ESR1—Ethinyl Estradiol—osteoporosis	0.0582	0.115	CbGbCtD
Naloxone—ESR1—Conjugated Estrogens—osteoporosis	0.0427	0.0841	CbGbCtD
Naloxone—ESR1—Estradiol—osteoporosis	0.0375	0.0738	CbGbCtD
Naloxone—ALB—Estropipate—osteoporosis	0.0296	0.0583	CbGbCtD
Naloxone—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0271	0.0533	CbGbCtD
Naloxone—SLCO1A2—Estradiol—osteoporosis	0.0238	0.0468	CbGbCtD
Naloxone—CYP2C8—Raloxifene—osteoporosis	0.0153	0.03	CbGbCtD
Naloxone—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0147	0.029	CbGbCtD
Naloxone—ALB—Estradiol—osteoporosis	0.0123	0.0242	CbGbCtD
Naloxone—CYP2C8—Cholecalciferol—osteoporosis	0.0118	0.0232	CbGbCtD
Naloxone—ABCB1—Ethinyl Estradiol—osteoporosis	0.00997	0.0196	CbGbCtD
Naloxone—CYP2C8—Estradiol—osteoporosis	0.0095	0.0187	CbGbCtD
Naloxone—CYP3A4—Estropipate—osteoporosis	0.00927	0.0183	CbGbCtD
Naloxone—CYP3A4—Calcitriol—osteoporosis	0.00927	0.0183	CbGbCtD
Naloxone—CYP3A4—Ergocalciferol—osteoporosis	0.00741	0.0146	CbGbCtD
Naloxone—ABCB1—Conjugated Estrogens—osteoporosis	0.00732	0.0144	CbGbCtD
Naloxone—ABCB1—Estradiol—osteoporosis	0.00643	0.0127	CbGbCtD
Naloxone—CYP3A4—Raloxifene—osteoporosis	0.00619	0.0122	CbGbCtD
Naloxone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00598	0.0118	CbGbCtD
Naloxone—CYP3A4—Cholecalciferol—osteoporosis	0.00478	0.00941	CbGbCtD
Naloxone—CYP3A4—Conjugated Estrogens—osteoporosis	0.00439	0.00864	CbGbCtD
Naloxone—CYP3A4—Estradiol—osteoporosis	0.00385	0.00758	CbGbCtD
Naloxone—Coma—Calcium Acetate—osteoporosis	0.00153	0.0176	CcSEcCtD
Naloxone—Abdominal cramps—Estropipate—osteoporosis	0.0014	0.0162	CcSEcCtD
Naloxone—Abdominal cramps—Calcitriol—osteoporosis	0.00132	0.0152	CcSEcCtD
Naloxone—Cardiac arrest—Calcium Acetate—osteoporosis	0.00115	0.0133	CcSEcCtD
Naloxone—Rhinorrhoea—Calcitriol—osteoporosis	0.0011	0.0127	CcSEcCtD
Naloxone—Ache—Estradiol—osteoporosis	0.00109	0.0125	CcSEcCtD
Naloxone—Abdominal cramps—Conjugated Estrogens—osteoporosis	0.000928	0.0107	CcSEcCtD
Naloxone—Injection site reaction—Ibandronate—osteoporosis	0.000904	0.0104	CcSEcCtD
Naloxone—Rhinorrhoea—Pamidronate—osteoporosis	0.000879	0.0101	CcSEcCtD
Naloxone—Pulmonary oedema—Ibandronate—osteoporosis	0.000809	0.00934	CcSEcCtD
Naloxone—Abdominal cramps—Estradiol—osteoporosis	0.000743	0.00857	CcSEcCtD
Naloxone—Hot flush—Raloxifene—osteoporosis	0.000713	0.00823	CcSEcCtD
Naloxone—Menopausal symptoms—Raloxifene—osteoporosis	0.000707	0.00816	CcSEcCtD
Naloxone—Irritability—Estropipate—osteoporosis	0.000657	0.00758	CcSEcCtD
Naloxone—Injection site reaction—Zoledronate—osteoporosis	0.000647	0.00747	CcSEcCtD
Naloxone—Pulmonary oedema—Pamidronate—osteoporosis	0.000634	0.00732	CcSEcCtD
Naloxone—Hot flush—Ethinyl Estradiol—osteoporosis	0.000596	0.00688	CcSEcCtD
Naloxone—Menopausal symptoms—Ethinyl Estradiol—osteoporosis	0.000591	0.00682	CcSEcCtD
Naloxone—Nasopharyngitis—Ibandronate—osteoporosis	0.00059	0.00681	CcSEcCtD
Naloxone—Nasopharyngitis—Calcitriol—osteoporosis	0.000578	0.00667	CcSEcCtD
Naloxone—Hypertension—Ergocalciferol—osteoporosis	0.000557	0.00642	CcSEcCtD
Naloxone—Hallucination—Etidronic acid—osteoporosis	0.000548	0.00632	CcSEcCtD
Naloxone—Paraesthesia—Calcium Acetate—osteoporosis	0.000535	0.00617	CcSEcCtD
Naloxone—Irritability—Ethinyl Estradiol—osteoporosis	0.000532	0.00615	CcSEcCtD
Naloxone—Depression—Estropipate—osteoporosis	0.000529	0.0061	CcSEcCtD
Naloxone—Depression—Raloxifene—osteoporosis	0.000512	0.00591	CcSEcCtD
Naloxone—Pain—Calcium Acetate—osteoporosis	0.000509	0.00588	CcSEcCtD
Naloxone—Depression—Ibandronate—osteoporosis	0.000507	0.00585	CcSEcCtD
Naloxone—Sweating—Raloxifene—osteoporosis	0.000493	0.00569	CcSEcCtD
Naloxone—Sweating—Ibandronate—osteoporosis	0.000488	0.00563	CcSEcCtD
Naloxone—Nasopharyngitis—Risedronate—osteoporosis	0.000486	0.00561	CcSEcCtD
Naloxone—Nasopharyngitis—Pamidronate—osteoporosis	0.000462	0.00534	CcSEcCtD
Naloxone—Pain—Ergocalciferol—osteoporosis	0.00045	0.00519	CcSEcCtD
Naloxone—Cardiac disorder—Estropipate—osteoporosis	0.000442	0.0051	CcSEcCtD
Naloxone—Irritability—Conjugated Estrogens—osteoporosis	0.000434	0.00501	CcSEcCtD
Naloxone—Angiopathy—Estropipate—osteoporosis	0.000432	0.00499	CcSEcCtD
Naloxone—Mediastinal disorder—Estropipate—osteoporosis	0.000429	0.00495	CcSEcCtD
Naloxone—Depression—Ethinyl Estradiol—osteoporosis	0.000429	0.00495	CcSEcCtD
Naloxone—Flushing—Raloxifene—osteoporosis	0.000428	0.00494	CcSEcCtD
Naloxone—Cardiac disorder—Raloxifene—osteoporosis	0.000428	0.00494	CcSEcCtD
Naloxone—Asthenia—Calcium Acetate—osteoporosis	0.000427	0.00493	CcSEcCtD
Naloxone—Cardiac disorder—Ibandronate—osteoporosis	0.000424	0.00489	CcSEcCtD
Naloxone—Nasopharyngitis—Zoledronate—osteoporosis	0.000422	0.00487	CcSEcCtD
Naloxone—Angiopathy—Raloxifene—osteoporosis	0.000418	0.00483	CcSEcCtD
Naloxone—Depression—Risedronate—osteoporosis	0.000418	0.00482	CcSEcCtD
Naloxone—Mental disorder—Estropipate—osteoporosis	0.000417	0.00481	CcSEcCtD
Naloxone—Angiopathy—Ibandronate—osteoporosis	0.000414	0.00478	CcSEcCtD
Naloxone—Mediastinal disorder—Ibandronate—osteoporosis	0.000412	0.00475	CcSEcCtD
Naloxone—Chills—Ibandronate—osteoporosis	0.00041	0.00473	CcSEcCtD
Naloxone—Diarrhoea—Calcium Acetate—osteoporosis	0.000408	0.0047	CcSEcCtD
Naloxone—Tension—Estropipate—osteoporosis	0.000407	0.00469	CcSEcCtD
Naloxone—Nervousness—Estropipate—osteoporosis	0.000403	0.00465	CcSEcCtD
Naloxone—Mental disorder—Ibandronate—osteoporosis	0.0004	0.00462	CcSEcCtD
Naloxone—Hot flush—Estradiol—osteoporosis	0.000389	0.00449	CcSEcCtD
Naloxone—Menopausal symptoms—Estradiol—osteoporosis	0.000386	0.00445	CcSEcCtD
Naloxone—Vomiting—Calcium Acetate—osteoporosis	0.000379	0.00437	CcSEcCtD
Naloxone—Asthenia—Ergocalciferol—osteoporosis	0.000377	0.00436	CcSEcCtD
Naloxone—Depression—Zoledronate—osteoporosis	0.000363	0.00419	CcSEcCtD
Naloxone—Agitation—Calcitriol—osteoporosis	0.000358	0.00413	CcSEcCtD
Naloxone—Nausea—Calcium Acetate—osteoporosis	0.000354	0.00408	CcSEcCtD
Naloxone—Paraesthesia—Etidronic acid—osteoporosis	0.000351	0.00405	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.00035	0.00404	CcSEcCtD
Naloxone—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00035	0.00404	CcSEcCtD
Naloxone—Depression—Conjugated Estrogens—osteoporosis	0.000349	0.00403	CcSEcCtD
Naloxone—Cardiac disorder—Risedronate—osteoporosis	0.000349	0.00403	CcSEcCtD
Naloxone—Irritability—Estradiol—osteoporosis	0.000347	0.00401	CcSEcCtD
Naloxone—Hypertension—Ibandronate—osteoporosis	0.000343	0.00396	CcSEcCtD
Naloxone—Angiopathy—Risedronate—osteoporosis	0.000341	0.00394	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000339	0.00392	CcSEcCtD
Naloxone—Mediastinal disorder—Risedronate—osteoporosis	0.000339	0.00391	CcSEcCtD
Naloxone—Mental disorder—Ethinyl Estradiol—osteoporosis	0.000338	0.0039	CcSEcCtD
Naloxone—Convulsion—Calcitriol—osteoporosis	0.000337	0.00389	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000336	0.00388	CcSEcCtD
Naloxone—Hypertension—Calcitriol—osteoporosis	0.000336	0.00388	CcSEcCtD
Naloxone—Cardiac disorder—Pamidronate—osteoporosis	0.000332	0.00383	CcSEcCtD
Naloxone—Flushing—Pamidronate—osteoporosis	0.000332	0.00383	CcSEcCtD
Naloxone—Nervous system disorder—Estropipate—osteoporosis	0.000332	0.00383	CcSEcCtD
Naloxone—Mental disorder—Risedronate—osteoporosis	0.00033	0.00381	CcSEcCtD
Naloxone—Skin disorder—Estropipate—osteoporosis	0.000329	0.00379	CcSEcCtD
Naloxone—Nasopharyngitis—Estradiol—osteoporosis	0.000325	0.00376	CcSEcCtD
Naloxone—Angiopathy—Pamidronate—osteoporosis	0.000325	0.00375	CcSEcCtD
Naloxone—Mediastinal disorder—Pamidronate—osteoporosis	0.000322	0.00372	CcSEcCtD
Naloxone—Nervous system disorder—Raloxifene—osteoporosis	0.000321	0.00371	CcSEcCtD
Naloxone—Chills—Pamidronate—osteoporosis	0.000321	0.0037	CcSEcCtD
Naloxone—Skin disorder—Raloxifene—osteoporosis	0.000318	0.00367	CcSEcCtD
Naloxone—Nervous system disorder—Ibandronate—osteoporosis	0.000318	0.00367	CcSEcCtD
Naloxone—Hyperhidrosis—Raloxifene—osteoporosis	0.000317	0.00366	CcSEcCtD
Naloxone—Skin disorder—Ibandronate—osteoporosis	0.000315	0.00364	CcSEcCtD
Naloxone—Hyperhidrosis—Ibandronate—osteoporosis	0.000314	0.00362	CcSEcCtD
Naloxone—Nausea—Ergocalciferol—osteoporosis	0.000313	0.00361	CcSEcCtD
Naloxone—Abdominal pain—Etidronic acid—osteoporosis	0.000309	0.00357	CcSEcCtD
Naloxone—Skin disorder—Calcitriol—osteoporosis	0.000308	0.00356	CcSEcCtD
Naloxone—Tension—Pamidronate—osteoporosis	0.000306	0.00353	CcSEcCtD
Naloxone—Paraesthesia—Estropipate—osteoporosis	0.000304	0.00351	CcSEcCtD
Naloxone—Flushing—Zoledronate—osteoporosis	0.000303	0.0035	CcSEcCtD
Naloxone—Cardiac disorder—Zoledronate—osteoporosis	0.000303	0.0035	CcSEcCtD
Naloxone—Nervousness—Pamidronate—osteoporosis	0.000302	0.00349	CcSEcCtD
Naloxone—Angiopathy—Zoledronate—osteoporosis	0.000296	0.00342	CcSEcCtD
Naloxone—Mediastinal disorder—Zoledronate—osteoporosis	0.000294	0.0034	CcSEcCtD
Naloxone—Chills—Zoledronate—osteoporosis	0.000293	0.00338	CcSEcCtD
Naloxone—Gastrointestinal disorder—Estropipate—osteoporosis	0.000292	0.00337	CcSEcCtD
Naloxone—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000292	0.00337	CcSEcCtD
Naloxone—Paraesthesia—Ibandronate—osteoporosis	0.000291	0.00336	CcSEcCtD
Naloxone—Pain—Estropipate—osteoporosis	0.000289	0.00334	CcSEcCtD
Naloxone—Mental disorder—Zoledronate—osteoporosis	0.000286	0.0033	CcSEcCtD
Naloxone—Agitation—Pamidronate—osteoporosis	0.000286	0.0033	CcSEcCtD
Naloxone—Angiopathy—Conjugated Estrogens—osteoporosis	0.000285	0.00329	CcSEcCtD
Naloxone—Pain—Alendronate—osteoporosis	0.000285	0.00329	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000284	0.00328	CcSEcCtD
Naloxone—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000284	0.00327	CcSEcCtD
Naloxone—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000283	0.00327	CcSEcCtD
Naloxone—Hypertension—Risedronate—osteoporosis	0.000283	0.00326	CcSEcCtD
Naloxone—Pain—Raloxifene—osteoporosis	0.00028	0.00323	CcSEcCtD
Naloxone—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00028	0.00323	CcSEcCtD
Naloxone—Depression—Estradiol—osteoporosis	0.00028	0.00323	CcSEcCtD
Naloxone—Pain—Ibandronate—osteoporosis	0.000277	0.0032	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000277	0.0032	CcSEcCtD
Naloxone—Mental disorder—Conjugated Estrogens—osteoporosis	0.000276	0.00318	CcSEcCtD
Naloxone—Pain—Calcitriol—osteoporosis	0.000272	0.00313	CcSEcCtD
Naloxone—Convulsion—Pamidronate—osteoporosis	0.00027	0.00311	CcSEcCtD
Naloxone—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000269	0.0031	CcSEcCtD
Naloxone—Hypertension—Pamidronate—osteoporosis	0.000269	0.0031	CcSEcCtD
Naloxone—Tension—Conjugated Estrogens—osteoporosis	0.000269	0.0031	CcSEcCtD
Naloxone—Diarrhoea—Etidronic acid—osteoporosis	0.000268	0.00309	CcSEcCtD
Naloxone—Abdominal pain—Estropipate—osteoporosis	0.000267	0.00309	CcSEcCtD
Naloxone—Body temperature increased—Estropipate—osteoporosis	0.000267	0.00309	CcSEcCtD
Naloxone—Tremor—Zoledronate—osteoporosis	0.000266	0.00308	CcSEcCtD
Naloxone—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000266	0.00307	CcSEcCtD
Naloxone—Nervousness—Conjugated Estrogens—osteoporosis	0.000266	0.00307	CcSEcCtD
Naloxone—Abdominal pain—Alendronate—osteoporosis	0.000263	0.00304	CcSEcCtD
Naloxone—Body temperature increased—Alendronate—osteoporosis	0.000263	0.00304	CcSEcCtD
Naloxone—Nervous system disorder—Risedronate—osteoporosis	0.000262	0.00303	CcSEcCtD
Naloxone—Agitation—Zoledronate—osteoporosis	0.000261	0.00302	CcSEcCtD
Naloxone—Skin disorder—Risedronate—osteoporosis	0.00026	0.003	CcSEcCtD
Naloxone—Abdominal pain—Raloxifene—osteoporosis	0.000259	0.00299	CcSEcCtD
Naloxone—Body temperature increased—Raloxifene—osteoporosis	0.000259	0.00299	CcSEcCtD
Naloxone—Abdominal pain—Ibandronate—osteoporosis	0.000256	0.00296	CcSEcCtD
Naloxone—Body temperature increased—Ibandronate—osteoporosis	0.000256	0.00296	CcSEcCtD
Naloxone—Abdominal pain—Calcitriol—osteoporosis	0.000251	0.0029	CcSEcCtD
Naloxone—Body temperature increased—Calcitriol—osteoporosis	0.000251	0.0029	CcSEcCtD
Naloxone—Nervous system disorder—Pamidronate—osteoporosis	0.000249	0.00288	CcSEcCtD
Naloxone—Vomiting—Etidronic acid—osteoporosis	0.000249	0.00287	CcSEcCtD
Naloxone—Tachycardia—Pamidronate—osteoporosis	0.000248	0.00286	CcSEcCtD
Naloxone—Convulsion—Zoledronate—osteoporosis	0.000246	0.00284	CcSEcCtD
Naloxone—Hyperhidrosis—Pamidronate—osteoporosis	0.000246	0.00284	CcSEcCtD
Naloxone—Hypertension—Zoledronate—osteoporosis	0.000246	0.00283	CcSEcCtD
Naloxone—Asthenia—Estropipate—osteoporosis	0.000243	0.0028	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00024	0.00278	CcSEcCtD
Naloxone—Paraesthesia—Risedronate—osteoporosis	0.00024	0.00277	CcSEcCtD
Naloxone—Asthenia—Alendronate—osteoporosis	0.000239	0.00276	CcSEcCtD
Naloxone—Dyspnoea—Risedronate—osteoporosis	0.000238	0.00275	CcSEcCtD
Naloxone—Convulsion—Conjugated Estrogens—osteoporosis	0.000237	0.00274	CcSEcCtD
Naloxone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000237	0.00273	CcSEcCtD
Naloxone—Flushing—Estradiol—osteoporosis	0.000234	0.0027	CcSEcCtD
Naloxone—Cardiac disorder—Estradiol—osteoporosis	0.000234	0.0027	CcSEcCtD
Naloxone—Asthenia—Ibandronate—osteoporosis	0.000233	0.00269	CcSEcCtD
Naloxone—Nausea—Etidronic acid—osteoporosis	0.000232	0.00268	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000232	0.00267	CcSEcCtD
Naloxone—Diarrhoea—Estropipate—osteoporosis	0.000231	0.00267	CcSEcCtD
Naloxone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000231	0.00266	CcSEcCtD
Naloxone—Pain—Risedronate—osteoporosis	0.000229	0.00264	CcSEcCtD
Naloxone—Angiopathy—Estradiol—osteoporosis	0.000228	0.00264	CcSEcCtD
Naloxone—Paraesthesia—Pamidronate—osteoporosis	0.000228	0.00263	CcSEcCtD
Naloxone—Diarrhoea—Alendronate—osteoporosis	0.000228	0.00263	CcSEcCtD
Naloxone—Asthenia—Calcitriol—osteoporosis	0.000228	0.00263	CcSEcCtD
Naloxone—Nervous system disorder—Zoledronate—osteoporosis	0.000228	0.00263	CcSEcCtD
Naloxone—Mediastinal disorder—Estradiol—osteoporosis	0.000227	0.00262	CcSEcCtD
Naloxone—Dyspnoea—Pamidronate—osteoporosis	0.000227	0.00262	CcSEcCtD
Naloxone—Tachycardia—Zoledronate—osteoporosis	0.000227	0.00261	CcSEcCtD
Naloxone—Chills—Estradiol—osteoporosis	0.000226	0.00261	CcSEcCtD
Naloxone—Skin disorder—Zoledronate—osteoporosis	0.000225	0.0026	CcSEcCtD
Naloxone—Hyperhidrosis—Zoledronate—osteoporosis	0.000224	0.00259	CcSEcCtD
Naloxone—Diarrhoea—Raloxifene—osteoporosis	0.000224	0.00259	CcSEcCtD
Naloxone—Diarrhoea—Ibandronate—osteoporosis	0.000222	0.00256	CcSEcCtD
Naloxone—Mental disorder—Estradiol—osteoporosis	0.000221	0.00255	CcSEcCtD
Naloxone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000219	0.00253	CcSEcCtD
Naloxone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000219	0.00253	CcSEcCtD
Naloxone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000218	0.00252	CcSEcCtD
Naloxone—Pain—Pamidronate—osteoporosis	0.000217	0.00251	CcSEcCtD
Naloxone—Diarrhoea—Calcitriol—osteoporosis	0.000217	0.00251	CcSEcCtD
Naloxone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000217	0.00251	CcSEcCtD
Naloxone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000217	0.0025	CcSEcCtD
Naloxone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000217	0.0025	CcSEcCtD
Naloxone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000216	0.00249	CcSEcCtD
Naloxone—Tension—Estradiol—osteoporosis	0.000215	0.00248	CcSEcCtD
Naloxone—Vomiting—Estropipate—osteoporosis	0.000215	0.00248	CcSEcCtD
Naloxone—Nervousness—Estradiol—osteoporosis	0.000213	0.00246	CcSEcCtD
Naloxone—Vomiting—Alendronate—osteoporosis	0.000212	0.00245	CcSEcCtD
Naloxone—Abdominal pain—Risedronate—osteoporosis	0.000211	0.00244	CcSEcCtD
Naloxone—Body temperature increased—Risedronate—osteoporosis	0.000211	0.00244	CcSEcCtD
Naloxone—Paraesthesia—Zoledronate—osteoporosis	0.000208	0.00241	CcSEcCtD
Naloxone—Vomiting—Raloxifene—osteoporosis	0.000208	0.0024	CcSEcCtD
Naloxone—Dyspnoea—Zoledronate—osteoporosis	0.000207	0.00239	CcSEcCtD
Naloxone—Vomiting—Ibandronate—osteoporosis	0.000206	0.00238	CcSEcCtD
Naloxone—Tremor—Estradiol—osteoporosis	0.000205	0.00237	CcSEcCtD
Naloxone—Vomiting—Calcitriol—osteoporosis	0.000202	0.00233	CcSEcCtD
Naloxone—Agitation—Estradiol—osteoporosis	0.000201	0.00232	CcSEcCtD
Naloxone—Nausea—Estropipate—osteoporosis	0.000201	0.00232	CcSEcCtD
Naloxone—Body temperature increased—Pamidronate—osteoporosis	0.000201	0.00232	CcSEcCtD
Naloxone—Abdominal pain—Pamidronate—osteoporosis	0.000201	0.00232	CcSEcCtD
Naloxone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000201	0.00232	CcSEcCtD
Naloxone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.0002	0.00231	CcSEcCtD
Naloxone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000199	0.0023	CcSEcCtD
Naloxone—Pain—Zoledronate—osteoporosis	0.000199	0.00229	CcSEcCtD
Naloxone—Nausea—Alendronate—osteoporosis	0.000198	0.00228	CcSEcCtD
Naloxone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000197	0.00227	CcSEcCtD
Naloxone—Nausea—Raloxifene—osteoporosis	0.000195	0.00225	CcSEcCtD
Naloxone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000193	0.00223	CcSEcCtD
Naloxone—Nausea—Ibandronate—osteoporosis	0.000193	0.00222	CcSEcCtD
Naloxone—Asthenia—Risedronate—osteoporosis	0.000192	0.00221	CcSEcCtD
Naloxone—Pain—Conjugated Estrogens—osteoporosis	0.000191	0.00221	CcSEcCtD
Naloxone—Hypertension—Estradiol—osteoporosis	0.000189	0.00218	CcSEcCtD
Naloxone—Nausea—Calcitriol—osteoporosis	0.000189	0.00218	CcSEcCtD
Naloxone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000188	0.00217	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000185	0.00214	CcSEcCtD
Naloxone—Abdominal pain—Zoledronate—osteoporosis	0.000184	0.00212	CcSEcCtD
Naloxone—Body temperature increased—Zoledronate—osteoporosis	0.000184	0.00212	CcSEcCtD
Naloxone—Diarrhoea—Risedronate—osteoporosis	0.000183	0.00211	CcSEcCtD
Naloxone—Asthenia—Pamidronate—osteoporosis	0.000182	0.0021	CcSEcCtD
Naloxone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000177	0.00204	CcSEcCtD
Naloxone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000177	0.00204	CcSEcCtD
Naloxone—Nervous system disorder—Estradiol—osteoporosis	0.000175	0.00202	CcSEcCtD
Naloxone—Tachycardia—Estradiol—osteoporosis	0.000175	0.00202	CcSEcCtD
Naloxone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000174	0.00201	CcSEcCtD
Naloxone—Diarrhoea—Pamidronate—osteoporosis	0.000174	0.00201	CcSEcCtD
Naloxone—Skin disorder—Estradiol—osteoporosis	0.000174	0.00201	CcSEcCtD
Naloxone—Hyperhidrosis—Estradiol—osteoporosis	0.000173	0.002	CcSEcCtD
Naloxone—Vomiting—Risedronate—osteoporosis	0.00017	0.00196	CcSEcCtD
Naloxone—Asthenia—Zoledronate—osteoporosis	0.000167	0.00192	CcSEcCtD
Naloxone—Nausea—Ethinyl Estradiol—osteoporosis	0.000163	0.00188	CcSEcCtD
Naloxone—Vomiting—Pamidronate—osteoporosis	0.000162	0.00187	CcSEcCtD
Naloxone—Paraesthesia—Estradiol—osteoporosis	0.000161	0.00185	CcSEcCtD
Naloxone—Asthenia—Conjugated Estrogens—osteoporosis	0.00016	0.00185	CcSEcCtD
Naloxone—Dyspnoea—Estradiol—osteoporosis	0.000159	0.00184	CcSEcCtD
Naloxone—Diarrhoea—Zoledronate—osteoporosis	0.000159	0.00183	CcSEcCtD
Naloxone—Nausea—Risedronate—osteoporosis	0.000159	0.00183	CcSEcCtD
Naloxone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000154	0.00178	CcSEcCtD
Naloxone—Pain—Estradiol—osteoporosis	0.000153	0.00177	CcSEcCtD
Naloxone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000153	0.00177	CcSEcCtD
Naloxone—Nausea—Pamidronate—osteoporosis	0.000151	0.00174	CcSEcCtD
Naloxone—Vomiting—Zoledronate—osteoporosis	0.000148	0.0017	CcSEcCtD
Naloxone—Vomiting—Conjugated Estrogens—osteoporosis	0.000142	0.00164	CcSEcCtD
Naloxone—Abdominal pain—Estradiol—osteoporosis	0.000141	0.00163	CcSEcCtD
Naloxone—Body temperature increased—Estradiol—osteoporosis	0.000141	0.00163	CcSEcCtD
Naloxone—Nausea—Zoledronate—osteoporosis	0.000138	0.00159	CcSEcCtD
Naloxone—Nausea—Conjugated Estrogens—osteoporosis	0.000133	0.00153	CcSEcCtD
Naloxone—Asthenia—Estradiol—osteoporosis	0.000128	0.00148	CcSEcCtD
Naloxone—Diarrhoea—Estradiol—osteoporosis	0.000122	0.00141	CcSEcCtD
Naloxone—Vomiting—Estradiol—osteoporosis	0.000114	0.00131	CcSEcCtD
Naloxone—Nausea—Estradiol—osteoporosis	0.000106	0.00123	CcSEcCtD
Naloxone—CREB1—Signaling Pathways—PSMA5—osteoporosis	1.71e-05	0.000186	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TLN1—osteoporosis	1.7e-05	0.000185	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PSMA2—osteoporosis	1.7e-05	0.000185	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PSMA5—osteoporosis	1.7e-05	0.000185	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGA—osteoporosis	1.7e-05	0.000185	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—IL6—osteoporosis	1.68e-05	0.000183	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ENO1—osteoporosis	1.68e-05	0.000183	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—ADCY5—osteoporosis	1.67e-05	0.000182	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—P4HB—osteoporosis	1.65e-05	0.00018	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PSMA2—osteoporosis	1.65e-05	0.00018	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PSMA5—osteoporosis	1.65e-05	0.00018	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ATIC—osteoporosis	1.65e-05	0.00018	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PNP—osteoporosis	1.65e-05	0.00018	CbGpPWpGaD
Naloxone—CREB1—Disease—ADCY5—osteoporosis	1.61e-05	0.000176	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTH—osteoporosis	1.61e-05	0.000175	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—OXCT1—osteoporosis	1.61e-05	0.000175	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CA2—osteoporosis	1.61e-05	0.000175	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL6—osteoporosis	1.6e-05	0.000174	CbGpPWpGaD
Naloxone—ALB—Metabolism—CA2—osteoporosis	1.6e-05	0.000174	CbGpPWpGaD
Naloxone—ALB—Metabolism—OXCT1—osteoporosis	1.6e-05	0.000174	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CALCA—osteoporosis	1.59e-05	0.000173	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CALCA—osteoporosis	1.58e-05	0.000173	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RAP1A—osteoporosis	1.58e-05	0.000172	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—BMP2—osteoporosis	1.58e-05	0.000172	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTHLH—osteoporosis	1.58e-05	0.000172	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CNR2—osteoporosis	1.57e-05	0.000171	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—MGLL—osteoporosis	1.57e-05	0.000171	CbGpPWpGaD
Naloxone—ALB—Metabolism—MGLL—osteoporosis	1.56e-05	0.00017	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—ADCY5—osteoporosis	1.56e-05	0.00017	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—POMC—osteoporosis	1.55e-05	0.000168	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGB—osteoporosis	1.54e-05	0.000168	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NFATC1—osteoporosis	1.54e-05	0.000168	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—ESR2—osteoporosis	1.54e-05	0.000167	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—DKK1—osteoporosis	1.53e-05	0.000167	CbGpPWpGaD
Naloxone—CREB1—Immune System—IRS2—osteoporosis	1.53e-05	0.000167	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—IL6—osteoporosis	1.52e-05	0.000166	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PSMA2—osteoporosis	1.49e-05	0.000162	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PSMA5—osteoporosis	1.49e-05	0.000162	CbGpPWpGaD
Naloxone—CREB1—Disease—MTHFR—osteoporosis	1.48e-05	0.000162	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.48e-05	0.000161	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—WNT1—osteoporosis	1.47e-05	0.000161	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.47e-05	0.00016	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—P4HB—osteoporosis	1.47e-05	0.00016	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—KL—osteoporosis	1.44e-05	0.000157	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TGFB1—osteoporosis	1.44e-05	0.000157	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—KL—osteoporosis	1.44e-05	0.000157	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGA—osteoporosis	1.43e-05	0.000156	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTH—osteoporosis	1.43e-05	0.000155	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—ADCY5—osteoporosis	1.41e-05	0.000154	CbGpPWpGaD
Naloxone—CREB1—Disease—IRS2—osteoporosis	1.41e-05	0.000154	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—POMC—osteoporosis	1.41e-05	0.000153	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—POMC—osteoporosis	1.4e-05	0.000153	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RAP1A—osteoporosis	1.4e-05	0.000153	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—OXCT1—osteoporosis	1.4e-05	0.000153	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CA2—osteoporosis	1.4e-05	0.000153	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CNR2—osteoporosis	1.39e-05	0.000151	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CALCA—osteoporosis	1.39e-05	0.000151	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL6R—osteoporosis	1.37e-05	0.00015	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL6R—osteoporosis	1.37e-05	0.000149	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NFATC1—osteoporosis	1.37e-05	0.000149	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—MGLL—osteoporosis	1.37e-05	0.000149	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—DKK1—osteoporosis	1.36e-05	0.000148	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—POMC—osteoporosis	1.36e-05	0.000148	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TNF—osteoporosis	1.35e-05	0.000147	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CYP19A1—osteoporosis	1.34e-05	0.000146	CbGpPWpGaD
Naloxone—CREB1—Immune System—IRS1—osteoporosis	1.34e-05	0.000145	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTHLH—osteoporosis	1.33e-05	0.000145	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—BMP2—osteoporosis	1.33e-05	0.000145	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—IDH2—osteoporosis	1.33e-05	0.000145	CbGpPWpGaD
Naloxone—ALB—Metabolism—IDH2—osteoporosis	1.33e-05	0.000144	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—WNT1—osteoporosis	1.31e-05	0.000142	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGB—osteoporosis	1.31e-05	0.000142	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGA—osteoporosis	1.27e-05	0.000139	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—KL—osteoporosis	1.26e-05	0.000137	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PSMA2—osteoporosis	1.26e-05	0.000137	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PSMA5—osteoporosis	1.26e-05	0.000137	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL6R—osteoporosis	1.25e-05	0.000137	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.25e-05	0.000136	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP27A1—osteoporosis	1.25e-05	0.000136	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—POMC—osteoporosis	1.24e-05	0.000135	CbGpPWpGaD
Naloxone—CREB1—Disease—IRS1—osteoporosis	1.23e-05	0.000134	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—POMC—osteoporosis	1.23e-05	0.000134	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ACP5—osteoporosis	1.22e-05	0.000133	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—VDR—osteoporosis	1.22e-05	0.000133	CbGpPWpGaD
Naloxone—ALB—Metabolism—ACP5—osteoporosis	1.21e-05	0.000132	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.2e-05	0.000131	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL6R—osteoporosis	1.2e-05	0.000131	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.2e-05	0.00013	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTHLH—osteoporosis	1.18e-05	0.000129	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—BMP2—osteoporosis	1.18e-05	0.000129	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CALCA—osteoporosis	1.17e-05	0.000128	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PKM—osteoporosis	1.17e-05	0.000128	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—FDPS—osteoporosis	1.17e-05	0.000128	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—IDH2—osteoporosis	1.16e-05	0.000126	CbGpPWpGaD
Naloxone—CREB1—Disease—IL6R—osteoporosis	1.16e-05	0.000126	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGB—osteoporosis	1.16e-05	0.000126	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—POMC—osteoporosis	1.15e-05	0.000125	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.14e-05	0.000124	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—TPI1—osteoporosis	1.13e-05	0.000123	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ADCY5—osteoporosis	1.13e-05	0.000123	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ADCY5—osteoporosis	1.13e-05	0.000123	CbGpPWpGaD
Naloxone—ALB—Metabolism—TPI1—osteoporosis	1.13e-05	0.000123	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PSMA2—osteoporosis	1.12e-05	0.000122	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PSMA5—osteoporosis	1.12e-05	0.000122	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PGLS—osteoporosis	1.11e-05	0.000121	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GPD2—osteoporosis	1.11e-05	0.000121	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ADCY5—osteoporosis	1.09e-05	0.000119	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SPP1—osteoporosis	1.09e-05	0.000119	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP27A1—osteoporosis	1.09e-05	0.000119	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GPX1—osteoporosis	1.09e-05	0.000119	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SPP1—osteoporosis	1.09e-05	0.000119	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—IL6—osteoporosis	1.09e-05	0.000118	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.09e-05	0.000118	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.07e-05	0.000117	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.07e-05	0.000116	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—KL—osteoporosis	1.07e-05	0.000116	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—P4HB—osteoporosis	1.07e-05	0.000116	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ACP5—osteoporosis	1.06e-05	0.000116	CbGpPWpGaD
Naloxone—ALB—Metabolism—P4HB—osteoporosis	1.06e-05	0.000115	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GAPDH—osteoporosis	1.05e-05	0.000114	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CALCA—osteoporosis	1.04e-05	0.000113	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—POMC—osteoporosis	1.04e-05	0.000113	CbGpPWpGaD
Naloxone—ALB—Metabolism—GAPDH—osteoporosis	1.04e-05	0.000113	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—RAP1A—osteoporosis	1.02e-05	0.000111	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ATIC—osteoporosis	1.02e-05	0.000111	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PNP—osteoporosis	1.02e-05	0.000111	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL6R—osteoporosis	1.01e-05	0.00011	CbGpPWpGaD
Naloxone—ALB—Metabolism—RAP1A—osteoporosis	1.01e-05	0.00011	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—MTHFR—osteoporosis	1.01e-05	0.00011	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—MYC—osteoporosis	1.01e-05	0.00011	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1e-05	0.000109	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	9.98e-06	0.000109	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IRS2—osteoporosis	9.89e-06	0.000108	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ADCY5—osteoporosis	9.88e-06	0.000108	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—TPI1—osteoporosis	9.87e-06	0.000108	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IRS2—osteoporosis	9.86e-06	0.000107	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—LEP—osteoporosis	9.68e-06	0.000105	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—LEP—osteoporosis	9.65e-06	0.000105	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—IL6—osteoporosis	9.6e-06	0.000105	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SPP1—osteoporosis	9.56e-06	0.000104	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL1B—osteoporosis	9.55e-06	0.000104	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—KL—osteoporosis	9.45e-06	0.000103	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IGF1—osteoporosis	9.33e-06	0.000102	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—P4HB—osteoporosis	9.28e-06	0.000101	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ESR1—osteoporosis	9.24e-06	0.000101	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ESR1—osteoporosis	9.21e-06	0.0001	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GAPDH—osteoporosis	9.11e-06	9.92e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.88e-06	9.68e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—RAP1A—osteoporosis	8.88e-06	9.67e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.83e-06	9.62e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IRS2—osteoporosis	8.65e-06	9.42e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IRS1—osteoporosis	8.64e-06	9.41e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CA2—osteoporosis	8.63e-06	9.4e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—OXCT1—osteoporosis	8.63e-06	9.4e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IRS1—osteoporosis	8.61e-06	9.38e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—LEP—osteoporosis	8.46e-06	9.22e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—MGLL—osteoporosis	8.41e-06	9.16e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ADCY5—osteoporosis	8.35e-06	9.1e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—POMC—osteoporosis	8.32e-06	9.06e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—POMC—osteoporosis	8.29e-06	9.03e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ENO1—osteoporosis	8.23e-06	8.97e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—ENO1—osteoporosis	8.19e-06	8.92e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PSMA2—osteoporosis	8.11e-06	8.84e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PSMA5—osteoporosis	8.11e-06	8.84e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL6R—osteoporosis	8.11e-06	8.84e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL6R—osteoporosis	8.09e-06	8.81e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SPP1—osteoporosis	8.08e-06	8.8e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ESR1—osteoporosis	8.08e-06	8.8e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PSMA2—osteoporosis	8.07e-06	8.79e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PSMA5—osteoporosis	8.07e-06	8.79e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—POMC—osteoporosis	8.05e-06	8.77e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IGF1—osteoporosis	8e-06	8.71e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IGF1—osteoporosis	7.97e-06	8.69e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IRS1—osteoporosis	7.55e-06	8.22e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ADCY5—osteoporosis	7.41e-06	8.07e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IRS2—osteoporosis	7.31e-06	7.96e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—POMC—osteoporosis	7.27e-06	7.92e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ENO1—osteoporosis	7.17e-06	7.81e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SPP1—osteoporosis	7.16e-06	7.8e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—IDH2—osteoporosis	7.15e-06	7.79e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—LEP—osteoporosis	7.15e-06	7.79e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL6R—osteoporosis	7.09e-06	7.72e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PSMA5—osteoporosis	7.07e-06	7.7e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PSMA2—osteoporosis	7.07e-06	7.7e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IGF1—osteoporosis	6.99e-06	7.62e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—MYC—osteoporosis	6.87e-06	7.48e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—TGFB1—osteoporosis	6.85e-06	7.46e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ESR1—osteoporosis	6.83e-06	7.44e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP27A1—osteoporosis	6.73e-06	7.33e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP19A1—osteoporosis	6.58e-06	7.17e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP19A1—osteoporosis	6.55e-06	7.13e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ACP5—osteoporosis	6.54e-06	7.13e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IRS2—osteoporosis	6.48e-06	7.06e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IRS1—osteoporosis	6.38e-06	6.95e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—LEP—osteoporosis	6.34e-06	6.91e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—POMC—osteoporosis	6.14e-06	6.69e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL6—osteoporosis	6.12e-06	6.66e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL6—osteoporosis	6.1e-06	6.64e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—TPI1—osteoporosis	6.08e-06	6.63e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL6R—osteoporosis	5.99e-06	6.53e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IGF1—osteoporosis	5.91e-06	6.44e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP19A1—osteoporosis	5.74e-06	6.25e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—P4HB—osteoporosis	5.72e-06	6.23e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IRS1—osteoporosis	5.66e-06	6.16e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GAPDH—osteoporosis	5.61e-06	6.11e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TGFB1—osteoporosis	5.6e-06	6.09e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL6—osteoporosis	5.59e-06	6.09e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—RAP1A—osteoporosis	5.47e-06	5.96e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—POMC—osteoporosis	5.45e-06	5.93e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ADCY5—osteoporosis	5.38e-06	5.86e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GPX1—osteoporosis	5.36e-06	5.84e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—ADCY5—osteoporosis	5.35e-06	5.83e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL6—osteoporosis	5.35e-06	5.82e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—GPX1—osteoporosis	5.33e-06	5.81e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL6R—osteoporosis	5.31e-06	5.79e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IGF1—osteoporosis	5.24e-06	5.71e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—IL6—osteoporosis	5.16e-06	5.62e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—MTHFR—osteoporosis	4.95e-06	5.39e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—MTHFR—osteoporosis	4.92e-06	5.36e-05	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MYC—osteoporosis	4.84e-06	5.27e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MYC—osteoporosis	4.81e-06	5.24e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TGFB1—osteoporosis	4.8e-06	5.22e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MYC—osteoporosis	4.79e-06	5.22e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TGFB1—osteoporosis	4.78e-06	5.21e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ADCY5—osteoporosis	4.69e-06	5.1e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GPX1—osteoporosis	4.67e-06	5.09e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL6—osteoporosis	4.52e-06	4.92e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ENO1—osteoporosis	4.42e-06	4.81e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PSMA2—osteoporosis	4.36e-06	4.74e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PSMA5—osteoporosis	4.36e-06	4.74e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—MTHFR—osteoporosis	4.31e-06	4.69e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MYC—osteoporosis	4.2e-06	4.58e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TGFB1—osteoporosis	4.19e-06	4.57e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—POMC—osteoporosis	3.96e-06	4.31e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—POMC—osteoporosis	3.93e-06	4.28e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL6—osteoporosis	3.61e-06	3.94e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL6—osteoporosis	3.6e-06	3.92e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MYC—osteoporosis	3.55e-06	3.87e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TGFB1—osteoporosis	3.54e-06	3.86e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.53e-06	3.85e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—POMC—osteoporosis	3.45e-06	3.75e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL6—osteoporosis	3.16e-06	3.44e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MYC—osteoporosis	3.15e-06	3.43e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TGFB1—osteoporosis	3.14e-06	3.42e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ADCY5—osteoporosis	2.89e-06	3.14e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GPX1—osteoporosis	2.88e-06	3.13e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL6—osteoporosis	2.67e-06	2.91e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—MTHFR—osteoporosis	2.66e-06	2.89e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL6—osteoporosis	2.37e-06	2.58e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—POMC—osteoporosis	2.12e-06	2.31e-05	CbGpPWpGaD
